HUP0402225A3 - Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them - Google Patents

Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them

Info

Publication number
HUP0402225A3
HUP0402225A3 HU0402225A HUP0402225A HUP0402225A3 HU P0402225 A3 HUP0402225 A3 HU P0402225A3 HU 0402225 A HU0402225 A HU 0402225A HU P0402225 A HUP0402225 A HU P0402225A HU P0402225 A3 HUP0402225 A3 HU P0402225A3
Authority
HU
Hungary
Prior art keywords
macrolide
compounds
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU0402225A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pliva Istrazivacki Inst D O O filed Critical Pliva Istrazivacki Inst D O O
Publication of HUP0402225A2 publication Critical patent/HUP0402225A2/hu
Publication of HUP0402225A3 publication Critical patent/HUP0402225A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
HU0402225A 2001-11-14 2002-11-13 Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them HUP0402225A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0127349.9A GB0127349D0 (en) 2001-11-14 2001-11-14 Macrolides
PCT/GB2002/005101 WO2003042228A1 (en) 2001-11-14 2002-11-13 Macrolides

Publications (2)

Publication Number Publication Date
HUP0402225A2 HUP0402225A2 (hu) 2005-02-28
HUP0402225A3 true HUP0402225A3 (en) 2006-01-30

Family

ID=9925777

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0402225A HUP0402225A3 (en) 2001-11-14 2002-11-13 Macrolide-compounds, process for their preparation and pharmaceutical compositions containing them

Country Status (20)

Country Link
US (1) US7202221B2 (enExample)
EP (1) EP1453846B1 (enExample)
JP (1) JP2005515978A (enExample)
CN (1) CN1307194C (enExample)
AR (1) AR037371A1 (enExample)
AT (1) ATE362479T1 (enExample)
BR (1) BR0214132A (enExample)
CA (1) CA2466975A1 (enExample)
DE (1) DE60220180T2 (enExample)
EA (1) EA007433B1 (enExample)
ES (1) ES2287332T3 (enExample)
GB (1) GB0127349D0 (enExample)
HR (1) HRP20040433A2 (enExample)
HU (1) HUP0402225A3 (enExample)
IL (1) IL161710A0 (enExample)
PL (1) PL371472A1 (enExample)
RS (1) RS41904A (enExample)
UA (1) UA77210C2 (enExample)
WO (1) WO2003042228A1 (enExample)
ZA (1) ZA200403684B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6995143B2 (en) * 2002-02-28 2006-02-07 Basilea Pharmaceutica Ag Macrolides with antibacterial activity
US7022679B2 (en) 2002-05-13 2006-04-04 Enanta Pharmaceuticals, Inc. Processes for the preparation of 6-11 bicyclic erythromycin derivatives
US7910558B2 (en) 2002-05-13 2011-03-22 Enanta Pharmaceuticals, Inc. Bridged macrocyclic compounds and processes for the preparation thereof
US7135573B2 (en) 2002-05-13 2006-11-14 Enanta Pharmaceuticals, Inc. Processes for the preparation of O-(6-Pyrazol-1-yl-pyridin-3-ylmethyl)-hydroxylamine
US6764998B1 (en) 2003-06-18 2004-07-20 Enanta Pharmaceuticals, Inc. 6,11-4C-bicyclic 9a-azalide derivatives
EP1503759B1 (en) * 2002-05-14 2008-12-17 The Regents Of The University Of California Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
US7091196B2 (en) 2002-09-26 2006-08-15 Rib-X Pharmaceuticals, Inc. Bifunctional heterocyclic compounds and methods of making and using same
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds
US6645941B1 (en) 2003-03-26 2003-11-11 Enanta Pharmaceuticals, Inc. 6,11-3C-bicyclic 9a-azalide derivatives
EP1628989B1 (en) * 2003-05-13 2006-12-20 Glaxo Group Limited Novel 14 and 15 membered-ring compounds
GB0310979D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310984D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310980D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
GB0310986D0 (en) * 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
US7276487B2 (en) 2003-09-23 2007-10-02 Enanta Pharmaceuticals, Inc. 9a, 11-3C-bicyclic 9a-azalide derivatives
US7265094B2 (en) 2004-01-09 2007-09-04 Enanta Pharmaceuticals, Inc. 9N-substituted 6-11 bicyclic erythromycin derivatives
EP2716647A3 (en) 2004-02-27 2014-08-20 Rib-X Pharmaceuticals, Inc. Macrocyclic compounds and methods of making and using the same
AU2005240849B2 (en) * 2004-05-06 2008-10-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Ester linked macrolides useful for the treatment of microbial infections
CA2566112A1 (en) * 2004-05-06 2005-11-17 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O Carbamate linked macrolides useful for the treatment of microbial infections
WO2006047167A2 (en) * 2004-10-21 2006-05-04 Janssen Pharmaceutica, N.V. 9 alkyl and 9 alkylidenyl 6-0 alkyl-11, 12 carbamate ketolide antimicrobials
GB0424961D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424958D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424959D0 (en) 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
GB0424951D0 (en) * 2004-11-11 2004-12-15 Glaxo Group Ltd Novel compounds
ES2428874T3 (es) * 2006-08-09 2013-11-12 Basilea Pharmaceutica Ag Nuevos macrólidos útiles contra las enfermedades inflamatorias y alérgicas
CN101541331A (zh) 2006-08-24 2009-09-23 沃克哈特研究中心 具有抗微生物活性的新颖大环内酯和酮内酯
US8410065B2 (en) 2008-02-08 2013-04-02 Basilea Pharmaceutica Ag Macrolides and their use
EP2435460B1 (en) 2009-05-27 2015-01-07 Wockhardt Limited Ketolide compounds having antimicrobial activity
RU2601550C2 (ru) 2010-12-09 2016-11-10 Вокхардт Лимитед Кетолидные соединения
EP2671887A4 (en) * 2011-01-31 2014-06-25 Meiji Seika Pharma Co Ltd NEW MAKROLIDE DERIVATIVES
CN103619849B (zh) 2011-03-01 2016-05-25 沃克哈特有限公司 酮内酯中间体的制备方法
CN119060110A (zh) * 2023-05-30 2024-12-03 北京理工大学 一种红霉素衍生物及其制备方法和应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0126344A2 (en) 1983-05-20 1984-11-28 Abbott Laboratories Tripeptide esters of therapeutic agents
US4742049A (en) * 1986-06-04 1988-05-03 Abbott Laboratories Semisynthetic erythromycin antibiotics
IL93936A (en) * 1989-03-28 1994-06-24 Abbott Lab History of 9-dioxo-21,9-epoxy - erythromycin, method of preparation History of 11-oxo and 11-hydroxy, and pharmaceutical preparations containing them
CA2064634C (en) * 1991-04-04 1998-08-04 James V. Heck 9-deoxo-8a-aza-8a-homoerythromycin a derivatives modified at the 4"- and8a-positions
ES2252784T3 (es) 1996-05-07 2006-05-16 Abbott Laboratories Compuestos a base de eritromicina 6-0 sustituida y tecnica de produccion.
EP0895999A1 (en) * 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
US6262030B1 (en) * 1998-11-03 2001-07-17 Pfizer Inc. Erythromycin derivatives
EE200100613A (et) 1999-05-24 2003-02-17 Pfizer Products Inc. 13-metüülerütromütsiini derivaadid
CA2380455C (en) 1999-08-24 2009-06-02 Abbott Laboratories 9a-azalides with antibacterial activity
WO2001063539A2 (en) 2000-02-24 2001-08-30 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
US6946446B2 (en) * 2000-02-24 2005-09-20 Abbott Laboratories Anti-infective agents useful against multidrug-resistant strains of bacteria
JP2002173498A (ja) 2000-09-27 2002-06-21 Hokuriku Seiyaku Co Ltd エリスロマイシン誘導体
GB0025688D0 (en) 2000-10-19 2000-12-06 Glaxo Group Ltd Macrolides

Also Published As

Publication number Publication date
AR037371A1 (es) 2004-11-03
US7202221B2 (en) 2007-04-10
EA007433B1 (ru) 2006-10-27
ATE362479T1 (de) 2007-06-15
DE60220180D1 (de) 2007-06-28
GB0127349D0 (en) 2002-01-02
IL161710A0 (en) 2004-09-27
US20050080025A1 (en) 2005-04-14
CN1307194C (zh) 2007-03-28
WO2003042228A1 (en) 2003-05-22
ZA200403684B (en) 2005-09-13
EP1453846B1 (en) 2007-05-16
BR0214132A (pt) 2004-09-14
CA2466975A1 (en) 2003-05-22
HRP20040433A2 (en) 2005-04-30
EA200400536A1 (ru) 2004-12-30
PL371472A1 (en) 2005-06-13
UA77210C2 (en) 2006-11-15
HUP0402225A2 (hu) 2005-02-28
RS41904A (sr) 2006-10-27
JP2005515978A (ja) 2005-06-02
CN1612888A (zh) 2005-05-04
DE60220180T2 (de) 2008-01-17
ES2287332T3 (es) 2007-12-16
EP1453846A1 (en) 2004-09-08

Similar Documents

Publication Publication Date Title
HUP0301187A3 (en) Novel benzyl-piperidine-derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0402264A3 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines process for preparing them, pharmaceutical compositions containing them and use thereof
HU229604B1 (en) 6-substituted pyrido-pyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0301069A3 (en) Novel biarylcarboxamides, process for their preparation, pharmaceutical compositions containing them and their use
HUP0402063A3 (en) Indole-2-carboxamides process for producing them, pharmaceutical compositions containing them and use thereof
HUP0401619A3 (en) Phenethanolamine derivatives, process for their preparation and pharmaceutical composition containing them
HU0103063D0 (en) New 2h-pyridazin-3-one derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0400040A2 (hu) Szulfonamidok, eljárás az előállításukra és ezeket tartalmazó gyógyszerkészítmények
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUP0102512A3 (en) Bridged indenopyrrolocarbazoles, process for their preparation, pharmaceutical compositions containing them and their use
HU0100489D0 (en) New piperidine-4-sulphonamide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0401107A3 (en) Novel benzo-fused heterocycles, their use process for their preparation and pharmaceutical compositions containing them
AU2003231920A8 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
HUP0302515A3 (en) Sulfanidothienopyrimidines, process for their preparation and pharmaceutical compositions containing them
HUP0401082A3 (en) Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them
HUP0204001A3 (en) Substituted aminomethyl-phenyl-cyclohexane derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0302429A3 (en) 4-amino-quinazolines, process for producing them, pharmaceutical compositions containing them and their use
HUP0301254A3 (en) Novel compounds, process fo their preparation and pharmaceutical compositions containing them
HUP0303361A3 (en) Substituted 1-aminobutan-3-ol derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0204394A3 (en) Tetrahydropyridines, process for their preparation, pharmaceutical compositions containing them and use thereof
HUP0401713A3 (en) Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same
HUP0401829A3 (en) Substituted (1h)-quinoxalin-2-one compounds and substituted 4-aryl- or 4-heteroarylcyclohexane compounds, process for their preparation and pharmaceutical compositions containing the (1h)-quinoxalin-2-one compounds
SI1241169T1 (en) Isoindoloindolone derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0300066A3 (en) Polypeptide compounds, process for their preparation and pharmaceutical compositions containing them
HUP0302905A3 (en) Triazolo-epothilone-analogs, process for their preparation and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees